Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy
Authors
Keywords
Pseudomonas aeruginosa, Bacteremia, Risk factors, Anti-bacterial agents, Combination, Mortality
Journal
BMC INFECTIOUS DISEASES
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-03-24
DOI
10.1186/1471-2334-14-161
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mortality, Length of Stay, and Cost Associated with Hospitalized Adult Cancer Patients with Febrile Neutropenia
- (2013) Jarin Chindaprasirt et al. Asian Pacific Journal of Cancer Prevention
- Surviving Sepsis Campaign
- (2013) R. Phillip Dellinger et al. CRITICAL CARE MEDICINE
- Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: predictors of early and crude mortality
- (2013) C. Peña et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii
- (2013) Ilkay Karaoglan et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- A prospective study of characteristics and outcomes of bacteremia in patients with solid organ or hematologic malignancies
- (2013) George Samonis et al. SUPPORTIVE CARE IN CANCER
- Influence of Multidrug Resistance and Appropriate Empirical Therapy on the 30-Day Mortality Rate of Pseudomonas aeruginosa Bacteremia
- (2012) Laura Morata et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Risk factors for pan-resistant Pseudomonas aeruginosa bacteremia and the adequacy of antibiotic therapy
- (2012) Felipe F. Tuon et al. Brazilian Journal of Infectious Diseases
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Pseudomonas aeruginosa bacteremia upon hospital admission: risk factors for mortality and influence of inadequate empirical antimicrobial therapy
- (2011) Vered Schechner et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009
- (2011) Kyungwon Lee et al. YONSEI MEDICAL JOURNAL
- Influence of carbapenem resistance on mortality and the dynamics of mortality in Pseudomonas aeruginosa bloodstream infection
- (2010) Cristina Suárez et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Clinical impact of imipenem-resistant Pseudomonas aeruginosa bloodstream infections
- (2009) Cristina Suárez et al. JOURNAL OF INFECTION
- Pandrug Resistance (PDR), Extensive Drug Resistance (XDR), and Multidrug Resistance (MDR) among Gram‐Negative Bacilli: Need for International Harmonization in Terminology
- (2008) Matthew E. Falagas et al. CLINICAL INFECTIOUS DISEASES
- Pseudomonas aeruginosa Serious Infections: Mono or Combination Antimicrobial Therapy?
- (2008) Matteo Bassetti et al. CURRENT MEDICINAL CHEMISTRY
- Inappropriate initial antimicrobial therapy as a risk factor for mortality in patients with community-onset Pseudomonas aeruginosa bacteraemia
- (2008) H. S. Cheong et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More